Seven Eight Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Seven Eight Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,600	Closed	-$192K	–	766
2016 Q1	$192K	Buy	+3,600	New	+$266K	0.08%	315

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Seven Eight Capital's ANAC Position: Q2 2016 in Review

Seven Eight Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 3,600 shares — an estimated $192K sold.

Seven Eight Capital first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $192K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Seven Eight Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Seven Eight Capital sold 3,600 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $192K.
Seven Eight Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Seven Eight Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $192K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Seven Eight Capital's 13F filing for Q2 2016, filed 12 Aug 2016.